Terms: = Thyroid cancer AND Neurokinin
5 results:
1. The substance P and neurokinin-1 receptor system in human thyroid cancer: an immunohistochemical study.
Isorna I; Esteban F; Solanellas J; Coveñas R; Muñoz M
Eur J Histochem; 2020 Apr; 64(2):. PubMed ID: 32363847
[TBL] [Abstract] [Full Text] [Related]
2. Radiopeptide imaging and therapy in Europe.
Ambrosini V; Fani M; Fanti S; Forrer F; Maecke HR
J Nucl Med; 2011 Dec; 52 Suppl 2():42S-55S. PubMed ID: 22144555
[TBL] [Abstract] [Full Text] [Related]
3. Regulatory peptides and other neuroendocrine markers in medullary carcinoma of the thyroid.
Hanna FW; Ardill JE; Johnston CF; Cunningham RT; Curry WJ; Russell CF; Buchanan KD
J Endocrinol; 1997 Feb; 152(2):275-81. PubMed ID: 9071985
[TBL] [Abstract] [Full Text] [Related]
4. Substance-P receptors in human primary neoplasms: tumoral and vascular localization.
Hennig IM; Laissue JA; Horisberger U; Reubi JC
Int J Cancer; 1995 Jun; 61(6):786-92. PubMed ID: 7790112
[TBL] [Abstract] [Full Text] [Related]
5. [Gastrointestinal hormone profile in medullary thyroid carcinoma].
Wirth HP; Eberle C; Meyenberger C; Bertschinger P; Häcki WH; Ammann R; Heitz PU
Schweiz Med Wochenschr; 1994 May; 124(21):906-11. PubMed ID: 8016606
[TBL] [Abstract] [Full Text] [Related]